CLINICAL_TRIALS trial_result · 2024-08-06

Clinical Trial Update: FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]

This Phase 2 trial update reports results on using FLT PET/CT to measure response in patients with previously untreated acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-08-06